Our analysis revealed significantly elevated expression levels in the expression profiles of TNFSF14, MXRA5, FCGR2B, and TNFRSF9 in GBM tissues compared to normal brain samples (Figure 3a–d). This evidence concerns the gene FCGR2B and glioblastoma.